Sage Journals: Discover world-class research

Free access

Research article

First published 2006-8

Cholinesterase Inhibitors in the Clinical Management of Alzheimer's Disease: Importance of Early and Persistent Treatment

B Seltzer

Journal of International Medical Research

Open access

Research article

First published 2014-1-24

Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors

Taher Darreh-Shori, Sharokh Makvand Hosseini, Agneta Nordberg

Journal of Alzheimer’s Disease

Retricted access

Review article

First published 2015-2-19

Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value

Roger M. Lane, Taher Darreh-Shori

Journal of Alzheimer’s Disease

Free access

Review article

First published 2014-12

Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease

David B Hogan

The Canadian Journal of Psychiatry

Free access

Research article

First published 2015-3

Effect of APOE and CHRNA7 Genotypes on the Cognitive Response to Cholinesterase Inhibitor Treatment at Different Stages of Alzheimer’s Disease

Ianna Lacerda Sampaio Braga, Patricia Natalia Silva, Tatiane Katsue Furuya [...]

American Journal of Alzheimer's Disease & Other Dementias®

Retricted access

Research article

First published 2021-11

Cholinesterase Inhibitor Use in Patients With Dementia Admitted to a Palliative Care Unit

Giulia-Anna Perri, Jessica Wilson, Sandra Gardner [...]

American Journal of Hospice and Palliative Medicine®

Retricted access

Research article

First published 2006-03

Beneficial Effect of Cholinesterase Inhibitor Medications on Recognition Memory Performance in Mild to Moderate Alzheimer’s Disease: Preliminary Findings

Timothy A. Crowell, Juno Paramadevan, Laila Abdullah [...]

Journal of Geriatric Psychiatry and Neurology

Free access

Research article

First published 2013-8

Prediction Models for Assessing Long-Term Outcome in Alzheimer’s Disease

Carina Wattmo

American Journal of Alzheimer's Disease & Other Dementias®

Free access

Review article

First published 2018-3

An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine

Rita Khoury, Jayashree Rajamanickam, George T. Grossberg

Therapeutic Advances in Drug Safety

Free access

Research article

First published 2016-8

Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors

Xiaodong Shi, Xiaotian Lin, Rui Hu [...]

American Journal of Alzheimer's Disease & Other Dementias®

Search results